Pharmaceutical News

RSS

Alexza Pharmaceuticals announces availability of ADASUVE inhalation powder in Guatemala

Alexza Pharmaceuticals, Inc. today announced that ADASUVE inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza.

8 Aug 2014

10th annual ‘Run for Her’ event to be held in LA to support ovarian cancer research

Registration is open for the 10th annual Run for Her® 5K Run and Friendship Walk, one of the nation's premier events to raise public awareness and research funds for the fight against ovarian cancer.

8 Aug 2014

Research highlights widespread use of sleeping medication use among astronauts

In an extensive study of sleep monitoring and sleeping pill use in astronauts, researchers from Brigham and Women's Hospital (BWH) Division of Sleep and Circadian Disorders, Harvard Medical School, and the University of Colorado found that astronauts suffer considerable sleep deficiency in the weeks leading up to and during space flight.

8 Aug 2014

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown.

8 Aug 2014

3SBio enters into exclusive license with DiNonA for development of Leukotuximab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL), in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and the Middle East (excluding Cyprus, Egypt, Israel and Turkey).

8 Aug 2014

Vitro toxicity testing an alternative to predict adverse health effects of drugs

In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.

8 Aug 2014

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate has been approved since January 2014 for adults with relapsing remitting multiple sclerosis.

8 Aug 2014

Secret of aging skin may lie in glycan and micronutrient creams

For decades, dermatologists have been researching the genetic cause of aging skin so that the perfect antidote could be developed. When examining genes and proteins, a difference between younger and older looking skin has not been found.

7 Aug 2014

New lifesaving product aims at reducing death toll from heroin abuse

A new, lifesaving product aimed at reducing the death toll from heroin abuse — developed by a professor at the University of Kentucky College of Pharmacy — is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

New tool promises to reduce deaths caused by heroin overdose

A new, lifesaving product aimed at reducing the death toll from heroin abuse - developed by a professor at the University of Kentucky College of Pharmacy - is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

New analysis outlines risks and benefits of taking aspirin to reduce risk of cancer

A new analysis published today outlines the risks and benefits of taking aspirin to reduce the risk of cancer.

7 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

Researchers plan to develop vaccine into a type of antibody serum therapy

By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.

7 Aug 2014

New study casts doubt on the effectiveness of brief counseling for illicit drug use

In an effort to stem substance use, the U.S. has invested heavily in the past decade in a brief screening-and-intervention protocol for alcohol and other drugs.

7 Aug 2014

Prompt administration of alteplase treatment reduces disability in stroke patients

Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.

7 Aug 2014

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.

7 Aug 2014

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.

7 Aug 2014

Study provides care coaches with useful ideas to help older patients improve asthma medication rituals

Storing it in the bathroom and making it part of a daily routine may be helpful advice that doctors can give their older asthmatic patients who struggle to remember to take their daily prescribed medication.

6 Aug 2014

Researchers identify genetic variants associated with severe skin reactions to antiepileptic drug

Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA.

6 Aug 2014

Blood cancer patients in the UK can now benefit from Roche's MabThera SC

Patients with one of the most common forms of blood cancer can now benefit from a new injection. MabThera subcutaneous (SC), which is given to patients just beneath the skin, can be administered in approximately five minutes, compared to the current two and a half hour intravenous (IV) infusion.

6 Aug 2014

Pharmaceutical News

Alexza Pharmaceuticals announces availability of ADASUVE inhalation powder in Guatemala

10th annual ‘Run for Her’ event to be held in LA to support ovarian cancer research

Research highlights widespread use of sleeping medication use among astronauts

Patients treated with drug for type 2 diabetes can live longer than people without the condition

3SBio enters into exclusive license with DiNonA for development of Leukotuximab

Vitro toxicity testing an alternative to predict adverse health effects of drugs

Dimethyl fumarate offers no added benefits for adults with RRMS

Secret of aging skin may lie in glycan and micronutrient creams

New lifesaving product aims at reducing death toll from heroin abuse

New tool promises to reduce deaths caused by heroin overdose

New analysis outlines risks and benefits of taking aspirin to reduce risk of cancer

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Researchers plan to develop vaccine into a type of antibody serum therapy

New study casts doubt on the effectiveness of brief counseling for illicit drug use

Prompt administration of alteplase treatment reduces disability in stroke patients

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Study provides care coaches with useful ideas to help older patients improve asthma medication rituals

Researchers identify genetic variants associated with severe skin reactions to antiepileptic drug

Blood cancer patients in the UK can now benefit from Roche's MabThera SC

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News